ETS1 and breast carcinoma: Given that both IL-8 and ETS1 expression correlate with the invasive phenotypes of cancer cells and angiogenesis [19, 43], our study provides further evidence of the multifaceted promotion of breast cancer progression by SHP2, in this case via upregulation of the pro-tumorigenic cytokine IL-8.